• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families.

作者信息

Cirello Valentina, Colombo Carla, Persani Luca, Fugazzola Laura

机构信息

Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

出版信息

Int J Cancer. 2019 Jul 15;145(2):600. doi: 10.1002/ijc.32244. Epub 2019 Mar 19.

DOI:10.1002/ijc.32244
PMID:30828786
Abstract
摘要

相似文献

1
Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families.在一系列意大利家族性非髓样甲状腺癌家族中未发现MAP2K5种系变体c.G961A和c.T1100C。
Int J Cancer. 2019 Jul 15;145(2):600. doi: 10.1002/ijc.32244. Epub 2019 Mar 19.
2
Authors' reply to: Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families. International Journal of Cancer 2019; in press.作者对《在一系列意大利家族性非髓样甲状腺癌中未发现MAP2K5基因种系变体c.G961A和c.T1100C》的回复。《国际癌症杂志》2019年；即将发表。
Int J Cancer. 2019 Jul 15;145(2):601-602. doi: 10.1002/ijc.32243. Epub 2019 Mar 19.
3
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.全外显子组和靶向测序鉴定 MAP2K5 为家族性非髓样甲状腺癌的新易感基因。
Int J Cancer. 2019 Mar 15;144(6):1321-1330. doi: 10.1002/ijc.31825. Epub 2018 Sep 24.
4
Is familial nonmedullary thyroid carcinoma more aggressive than sporadic nonmedullary thyroid carcinoma?家族性非髓样甲状腺癌比散发性非髓样甲状腺癌更具侵袭性吗？
Thyroid. 2014 Apr;24(4):782-3. doi: 10.1089/thy.2013.0694. Epub 2014 Mar 4.
5
Reply to the Letter to the Editor 'Germline-somatic fluidity in guiding patient care. Reply to the Letter to the Editor "Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients" by J. C. Rubinstein et al.' by E. Hahn & G. S. Charames.对编辑来信《生殖系-体细胞的流动性在指导患者护理中的作用。对J. C. 鲁宾斯坦等人的编辑来信〈对照组织的选择对一组甲状腺乳头状癌患者生殖系变异的认定的影响〉的回复》的回复，作者为E. 哈恩和G. S. 查拉姆斯
Ann Oncol. 2020 Aug;31(8):1090-1091. doi: 10.1016/j.annonc.2020.04.482. Epub 2020 May 16.
6
Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.家族性非髓样甲状腺癌中体 TERT 启动子突变的鉴定。
Clin Endocrinol (Oxf). 2017 Oct;87(4):394-399. doi: 10.1111/cen.13375. Epub 2017 Jun 19.
7
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.T1799A BRAF突变并非家族性非髓样甲状腺癌中的种系突变。
Clin Endocrinol (Oxf). 2005 Sep;63(3):263-6. doi: 10.1111/j.1365-2265.2005.02332.x.
8
Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.在西班牙人群中，频繁和罕见的 HABP2 变异与家族性非髓样甲状腺癌易感性增加无关。
Horm Res Paediatr. 2018;89(6):397-407. doi: 10.1159/000487395. Epub 2018 Jun 12.
9
Aggressiveness in familial nonmedullary thyroid carcinoma--the controversy continues.家族性非髓样甲状腺癌的侵袭性——争议仍在继续。
Thyroid. 2014 Apr;24(4):783-4. doi: 10.1089/thy.2014.0076.
10
RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.主题：家族性非髓样甲状腺癌中的HABP2 G534E突变
J Natl Cancer Inst. 2016 Jul 14;108(8). doi: 10.1093/jnci/djw143. Print 2016 Aug.

引用本文的文献

1
Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer.非综合征性家族性甲状腺癌中突变基因的染色体定位
Front Oncol. 2024 Mar 20;14:1286426. doi: 10.3389/fonc.2024.1286426. eCollection 2024.
2
Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.与非综合征性家族性非髓样甲状腺癌相关的易感性基因和染色体区域：一些发病机制和诊断关键。
Front Endocrinol (Lausanne). 2022 Feb 28;13:829103. doi: 10.3389/fendo.2022.829103. eCollection 2022.
3
Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing.
通过全外显子组测序鉴定NID1作为家族性非髓样甲状腺癌的新型候选易感基因。
Endocr Connect. 2022 Jan 31;11(1):e210406. doi: 10.1530/EC-21-0406.
4
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.家族性非髓样甲状腺癌的大型单中心系列的临床和遗传特征。
Front Endocrinol (Lausanne). 2021 Jan 7;11:589340. doi: 10.3389/fendo.2020.589340. eCollection 2020.
5
An update on familial nonmedullary thyroid cancer.家族性非髓样甲状腺癌的最新进展。
Endocrine. 2020 Jun;68(3):502-507. doi: 10.1007/s12020-020-02250-3. Epub 2020 Mar 11.